irs program accomplishments · form 990 part iii · fy2024
What they reported doing
- #1 primary $125KCOLUMBIA UNIVERSITY IRVING MEDICAL CENTER WAS GIVEN A GRANT FOR RESEARCH ON PCF DEVELOPMENTAL THERAPEUTICS TO COMBAT RECURING CANCERS OR CANCERS THAT DO NOT RESPOND TO TRADITIONAL TREATMENT METHODS.
- #2 $200KTHE WESTCHESTER MEDICAL CENTER WAS PROVIDED A GRANT IN CONCECTION WITH THEIR PROGRAM FOR REDUCING THE BURDEN OF ONCOLOGIC CHEMOTHERAPY AND RADIATION EXPOSURE UTILIZING TARGETED IMMUNOTHERAPY IN CHILDREN ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMA.
named programs · 3 · from sources
What they call their work
FLT3 Killer T Cell Immunotherapy for High-Risk Pediatric Leukemias
Funds a first-in-human phase 1 clinical trial at Children's Hospital of Philadelphia targeting FLT3 receptor protein in high-risk pediatric leukemias, particularly AML and KMT2A-rearranged ALL
Junior Committee
Youth-led program engaging high school students in fundraising and awareness activities to support pediatric cancer research
Pediatric Oncology Early Phase Clinical Trial Program (PEPCTP)
Supports early phase clinical trials at The Children’s Hospital at Montefiore for relapsed/refractory pediatric cancer patients in an underserved population
activities · 2 groups
What they do
-
Cancer Research Funding 3 activities
- Advocating for increased federal funding for pediatric cancer researchHighlights systemic underfunding in pediatric cancer research, specifically that less than 4% of federal cancer research dollars are allocated to children’s cancers, to raise awareness and advocate for greater investment.
- Funding pediatric cancer research programsAwards grants to support childhood cancer research initiatives across the United States, including rare and overlooked forms of pediatric cancers. Funds research projects that undergo medical advisory board review and monitors progress through annual reports and ongoing oversight.
- Funding specific clinical trials and targeted therapiesFinances innovative treatment development, including a first-in-human phase 1 clinical trial testing FLT3-targeted CAR T-cell immunotherapy for high-risk pediatric leukemias, as well as programs to reduce chemotherapy and radiation exposure through targeted immunotherapy at Westchester Medical Center.
-
-
Charity Event Organization 2 activities
- Hosting annual and recurring benefit eventsHosts and organizes large-scale fundraising events including galas, golf outings, tennis events, happy hours, and themed activities such as “Swing for the Stars,” “Drive Dream Hope,” and “Steps n Sips” in partnership with organizations like the Navis Foundation to support pediatric cancer patients and research.
- Supporting student-led and community fundraising eventsOrganizes and supports a network of over 60 high school student members across the U.S. who lead local fundraising efforts such as bake sales, trivia nights, fitness classes, concerts, retail collaborations, and school clubs. Also facilitates mall-based events and interest-aligned initiatives in areas like music, sports, and fashion to raise funds for pediatric cancer research.
-
financials · form 990 · fy2024
revenue
Total revenue$1.24M
Contributions & grants$923K75%
Program service revenue$00%
Investment income$182K15%
Other revenue$131K
expenses
Total expenses$1.15M
Program expenses78%
Admin / overhead12%
Fundraising10%
Salaries & benefits$0
Grants paid out$899K
Largest expense lineProfessional Fees
balance sheet
Total assets$5.96M
Cash$1.02M
Investments$4.86M
Liabilities$0
Net assets$5.96M
Liquid reserves61.2 mo
6 years on record · 2019–2024 · YoY revenue +52.0%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 3
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| PAMELA STRAUSS PELIGRI | EXECUTIVE DI | 40 | $100K |
| NANCY JOSELSON | MANAGER | 20 | $46K |
| DINA COHEN | OPERATIONS | 20 | $26K |
board members · 12
- ALISON PEPPER ATANASIO — TRUSTEE
- AMY ANDERSON — TRUSTEE
- COURTNEY SCHLESINGER — TRUSTEE
- DYLAN POSNER — TRUSTEE
- JAMIE HEIBERGER HARRISON — TRUSTEE
- JAY CANELL — TRUSTEE
- MEREDITH PERL — TRUSTEE
- MINDY SHULMAN — TRUSTEE
- NEIL CANELL — TRUSTEE
- SAM TAUBENFELD — TRUSTEE
- SINDIE SCHUR — TRUSTEE
- WENDY COHEN — TRUSTEE
relationships · 24
Who they work with
- Children's Hospital Los Angeles Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Children's Hospital of Philadelphia Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Children's Hospital of Philadelphia Partner — Funded to conduct a first-in-human phase 1 clinical trial for FLT3-targeted CAR T-cell therapy in high-risk pediatric leukemias.
- Children’s Hospital Colorado Partner — Collaborates with Children's Hospital of Philadelphia on the development and testing of FLT3 CAR T-cell immunotherapy for pediatric leukemias.
- Columbia University College of Physicians and Surgeons Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Columbia University Irving Medical Center Partner — Receives grants from PEDIATRIC CANCER FOUNDATION for pediatric cancer research and developmental therapeutics.
- Comer Children's Hospital, The University of Chicago Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Hassenfeld Children’s Center at NYU Langone Medical Center Partner — Receives funding from PEDIATRIC CANCER FOUNDATION for research and testing involving affected children, including researcher support and equipment upgrades.
- Icahn School of Medicine at Mount Sinai Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Instagram Partner — Platform used to share behind-the-scenes content of Junior Committee activities and student-led impact.
- Johns Hopkins University Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Maria Fareri Children's Hospital at Westchester Medical Center Partner — Receives funding from PEDIATRIC CANCER FOUNDATION to support its pediatric oncology unit for integrative medicine.
- Medical Advisory Board Partner — Group of oncologists that evaluates grant proposals using a multi-faceted rubric system.
- Medical Advisory Board Partner — Provides expert review and oversight of funded research projects.
- Memorial Sloan Kettering Cancer Center Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Montefiore Medical Center Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- NYU Grossman School of Medicine Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- NYU Langone Health Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Navis Foundation Partner — Co-hosted tennis and golf events with the Pediatric Cancer Foundation.
- New York Medical College Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- The Children’s Hospital at Montefiore Partner — Hosts the Pediatric Oncology Early Phase Clinical Trial Program (PEPCTP) funded by Pediatric Cancer Foundation.
- The Ohio State University Comprehensive Cancer Center Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- University of Michigan Medical School Partner — Designated as an elite hospital receiving support from Pediatric Cancer Foundation.
- Westchester Medical Center Partner — Receives grants from PEDIATRIC CANCER FOUNDATION for a program using targeted immunotherapy to reduce chemotherapy and radiation burden in young patients with lymphoma.
strategies · 2
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Science-Driven, Peer-Reviewed Grantmakingmethodology: peer_reviewed_grantmakingBy funding high-impact pediatric cancer research selected through a rigorous, peer-reviewed process led by a Medical Advisory Board, the foundation maximizes scientific return on investment because structured expert evaluation identifies the most promising preclinical and clinical work for bench-to-bedside translation.
- Targeted Funding for Underserved Populationsmethodology: targeted_funding_for_underserved_populationsBy directing research funding toward early-phase clinical trials for pediatric cancers in underserved and under-resourced populations, the foundation increases equitable access to novel therapies because addressing disparities in access accelerates both patient impact and therapeutic development.